Water Vapor Ablation for Prostate Cancer: Long-Term Registry

Recruiting now

Conditions studied: Prostate Cancer

In brief

The purpose of the registry is to evaluate real-world safety, efficacy, and patient reported outcomes among participants receiving Vanquish Water Vapor Ablation System therapy (Vanquish Therapy). This includes longitudinal assessment of patients who have received or will receive the therapy one or multiple times as part of routine clinical care and encompasses those who completed a company-sponsored Vanquish therapy study (as applicable).

Key facts

Study ID

NCT07455058

Run by

Francis Medical Inc.

People needed

2500

Starts

2026-06-05

Expected to finish

2041-07-31

Last updated by the study team

2026-06-12

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Candidate for Vanquish therapy per physician discretion or participant has completed a company-sponsored Vanquish therapy study.
• Participant is willing and able to provide written informed consent.

You may not qualify if…

• Contraindications per the Vanquish IFU
• Previously participated in VAPOR 2 study and is not planning to receive further Vanquish therapy.

Where it is running

• The Urology Place, Inc. — San Antonio, Texas, United States (enrolling)
• Urology of Virginia — Virginia Beach, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.